BenevolentAI SPAC Presentation Deck

Our mission: Uniting human and artificial intelligence to discover new ways to treat disease BenevolentAl is at the forefront of a revolution in drug discovery and development As biomedical research and data expand exponentially, the opportunity emerges to understand biology better • We combine advanced Al and machine learning with cutting edge science to decipher complex disease biology and discover optimum therapeutic interventions

View entire presentation